![](https://bartslifesciences.org/wp-content/uploads/2021/05/cancer-150x150.jpg)
COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London
Led by UKRI Rutherford research fellow Dayem Ullah and Professor of bioinformatics Claude Chelala, Barts Cancer Institute and Queen Mary University of London have published a study on the effects of COVID-19 in patients with hepatobiliary and pancreatic diseases in East London Read the full article here: https://bmjopen.bmj.com/content/11/4/e045077.full